CONCORD BIOTECH LIMITED

Scale -

Ebitda is 420 Rs Cr; in Top Quartile; Annual Decline is -24 %
PAT is 256 Rs Cr; in Top Quartile; Annual Decline is -31 %

PBT is 77.07 Rs Cr; Annual Decline is -31 %

Profitability -

PBDIT Margin is 39.79 %; in Top Quartile; Annual Decline is -13 %
PAT Margin is 24.29 %; in Top Quartile; Annual Decline is -22 %; 5 Year CAGR is -10 %
Quarterly Ebitda Margin is 32 %; in Top Quartile
Quarterly Profit margin is 22 %; in Top Quartile

Return -

ROA is 11.67 %; in Top Quartile; Annual Decline is -36 %; 5 Year CAGR is -20 %

ROCE is 16.71 %; Annual Decline is -38 %; 5 Year CAGR is -20 %
ROE is 12.93 %; Annual Decline is -37 %; 5 Year CAGR is -20 %
Asset Turnover is 49 %; Annual Decline is -23 %; in Bottom Quartile

Efficiency -

Quick Ratio is 5.46; Continuous Growth over 3 years; in Top Quartile
Current Ratio is 7.39; in Top Quartile
Inventory Turnover Ratio is 3.73; 5 Year CAGR is 106 %; Annual Decline is -30 %

Solvancy -

Total Debt is 0 Rs Cr; Annual Decline is -100 %; Continuous Decline over 3 years; in Bottom Quartile
Debt/Equity is 0; in Bottom Quartile

Quality -

Operating cashflow/ebitda is 64 %; Annual Growth is 43 %
Operating cashflow/PAT is 104 %; Annual Growth is 59 %
Change in Inventories/Total Expenses is -9 %; Annual Decline is -373 %; Continuous Decline over 3 years; in Bottom Quartile

Other Expenses/Total Expenses is 35 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: